SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-14-010903
Filing Date
2014-02-21
Accepted
2014-02-21 06:04:20
Documents
1
Period of Report
2014-02-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 v369250_form4.html 4  
1 FORM 4 v369250_form4.xml 4 5820
  Complete submission text file 0001144204-14-010903.txt   7291
Mailing Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE, SUITE 200 LA JOLLA CA 92037 858-964-5123
INNOVUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001411879 (see all company filings)

IRS No.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIO-QUANT, INC. 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO CA 92121
Business Address
Damaj Bassam (Reporting) CIK: 0001478733 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52991 | Film No.: 14631576